Premium
Technetium‐99 m human serum albumin in the differentiation of cerebrovascular and neoplastic lesions
Author(s) -
Jones A. E.,
Dunson G. L.,
Kyle R. W.,
Shamloo M.
Publication year - 1971
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.2930030610
Subject(s) - vascularity , pertechnetate , technetium , medicine , human serum albumin , albumin , technetium 99m , technetium 99 , nuclear medicine , pathology , radiology , scintigraphy , chemistry , chromatography
Technetium‐99m pertechnetate and technetium‐99m human serum albumin have been used within a 24‐hr interval to evaluate the vascularity of abnormalities detected on routine technetium‐99 m pertechnetate brain scans. Human serum albumin tagged with technetium‐99 m has provided superior resolution of vascular lesions on static images but offered no advantage over technetium‐99 m pertechnetate for early static imaging of neoplastic lesions. The use of technetium‐99 m human serum albumin in the resolution of suspicious areas observed on routine technetium‐99 m pertechnetate static scans is advised because it (1) more accurately detects vascular lesions, (2) serves better to indicate their total vascularity, and (3) will differentiate vascular lesions from neoplastic lesions.